Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep regulation with TEAS combined with esketamine in surgical patients
ChiCTR2400080894Phase 4Not yet recruiting
- Sponsor
- Xuzhou Traditional Chinese Medicine Hospital
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in sleep disorder, major depressive disorder (MDD) and postoperative pain (4 arms), sponsored by Xuzhou Traditional Chinese Medicine Hospital. Primary endpoints: Heart rate variability (HRV), Sleep quality and 1 more. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
sleep disordermajor depressive disorder (MDD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2400080894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080894.